| Open Document File Size: 569,83 KBShare Result on Facebook
Company HCTZ hydrochlorothiazide HF / Day 30 Cardiokine Biopharma LLC / Cardiokine Biopharma LLC / 61 Cardiokine Biopharma LLC / ITT / Alteon Inc. / / Currency pence / / Event FDA Phase / M&A / / Facility Central laboratory / hospital DDI / / IndustryTerm Treatment of Symptomatic Euvolemic Hyponatremia Associated with Syndrome / / MedicalCondition OF HYPONATREMIA / osmotic demyelination syndrome / Hyponatremia / Hyponatremia Hyponatremia / SE standard error SIADH syndrome / Heart Failure / Hypervolemic Hyponatremia / SIADH / Euvolemic Hyponatremia / chronic / Syndrome / euvolemic and hypervolemic hyponatremia / / Organization FDA / / Person Lixivaptan Dosing / / Position General / EXECUTIVE / / Product Heart Failure Lixivaptan Capsules / Vaprisol / hydrochlorothiazide / SAMSCA® / H20 / Heart / Incidence / Lixivaptan / P450 / Vaprisol® / /
SocialTag |
Cardiokine Biopharma, LLC Lixivaptan Briefing Document NDA 203,009 Page 1 of 61